Orlistat improves cardiovascular (CV) risk factors as well as reducing weight in overweight people with hypertension and type 2 diabetes mellitus

Source: Inpharma, Volume 1, Number 1586, 2007-05-05 , pp. 17-17(1)

Publisher: Adis International

Keywords: Cardiovascular-disorders, prevention; Obesity, treatment; Orlistat, therapeutic use; Trial-result-clinical; Type-2-diabetes-mellitus, prevention

Document Type: Short communication

Publication date: 2007-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers